Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016047

EVP and Chief Legal Officer sold 3,161 shares at $45.25 ($143,035)

  • EVP and Chief Legal Officer acquired 24,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and Chief Legal Officer 2023-03-01 Grant or award +2,663 37,101 D: show line 1 in the form
Parschauer Karah Herdman EVP and Chief Legal Officer 2023-03-01 Grant or award +22,000 59,101 D: show line 2 in the form
Parschauer Karah Herdman EVP and Chief Legal Officer 2023-03-01 Sale −3,161 $45.25 $143,035 56,139 D: show line 3 in the form
Open-market sales · 3,161 sh · avg $45.25 · $143,035

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Parschauer Karah Herdman EVP and Chief Legal Officer 2023-03-01 Grant or award · Stock Option (Right to Buy) +39,400 39,400 D: show line 4 in the form
Loading xslF345X03/doc4.xml…